Skip to main content
logo
ImmuPharma plc (AIM:IMM)
London flag London · Delayed Price · Currency is GBP · Price in GBX
4.390
+0.290 (7.07%)
Aug 14, 2026, 4:45 PM GMT

ImmuPharma Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
273157617
Market Cap Growth
241.49%521.13%-27.71%13.16%-62.85%-50.56%
Enterprise Value
263147613
Last Close Price
0.040.060.010.020.020.07

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-48.0448.0448.0448.0448.04
PS Ratio
-----139.54
PB Ratio
39.8845.38-9.246.572.433.74
P/TBV Ratio
39.8845.38-6.852.503.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----109.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.97-1.970.44-0.20-0.26-0.37
Net Debt / EBITDA Ratio
0.540.540.110.070.230.33
Net Debt / FCF Ratio
0.570.570.130.150.270.34
Asset Turnover
-----0.01
Quick Ratio
1.461.460.440.541.391.76
Current Ratio
1.521.520.580.811.612.11
Return on Equity (ROE)
-2510.61%-2510.61%-967.41%-163.24%-109.77%-116.20%
Return on Assets (ROA)
-110.91%-110.91%-76.76%-57.18%-37.97%-38.13%
Return on Capital Employed (ROCE)
-368.90%-368.90%418.40%-290.00%-120.00%-116.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.60%-5.80%-49.49%-42.09%-62.07%-49.49%
FCF Yield
-8.67%-7.62%-35.29%-19.65%-39.99%-29.57%
Buyback Yield / Dilution
-17.81%-17.81%-15.04%-19.51%-20.60%-25.47%